Monoamine oxidase inhibitors (MAOI) are recognized to extend and greatly enhance the effects of dimethyltryptamine (copyright) and a single study assumed the effect on psilocybin will be very similar as it is a structural analogue of copyright.[one hundred forty five] Even so, only a little part of psilocin appears for being metabolized by MAO.[16]